Learn more

RHONE POULENC RORER PHARMA

Overview
  • Total Patents
    397
About

RHONE POULENC RORER PHARMA has a total of 397 patent applications. Its first patent ever was published in 1985. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are EHJSAJ KO LTD, AVENTIS PHARMACEUTICALS PRODUCTS INC and SHARPS ASS.

Patent filings per year

Chart showing RHONE POULENC RORER PHARMAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Spada Alfred P 123
#2 Myers Michael R 72
#3 Ewing William R 49
#4 Maguire Martin P 46
#5 Klein Scott I 45
#6 Becker Michael R 41
#7 Pauls Henry W 40
#8 Molino Bruce F 35
#9 Choi-Sledeski Yong Mi 34
#10 Persons Paul E 33

Latest patents

Publication Filing date Title
GB9930535D0 Method
GB9930540D0 Chemical compounds
GB9924155D0 Chemical compounds
GB9926058D0 Therapeutic proteins
ZA9900729B Method for preparing an N-[(aliphatic or aromatic) carbonyl)]-2- aminoacetamide compound, and a cyclyzed compound.
ZA9811577B Method and reagents for the quantification of solid-phase reactions using fluorine NMR.
AU1589099A Functionalized resin for the synthesis of amides and peptides
ZA9809465B Therapeutic uses of quinoline derivatives.
WO9919294A1 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
US6034093A Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
ZA984573B Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561lck tyrosine kinases
CZ9904022A3 Peptide analogs of parathyroidal hormone
WO9833827A1 Elastomer treatment process to decrease peroxide levels
WO9832734A1 SUBSTITUTED β-THIOCARBOXYLIC ACIDS
ZA9711453B Process for the solid phase synthesis of aldehydes ketones oximes amines and hydroxamic acid compounds
WO9829376A1 Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds
ZA9710999B LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies.
CZ211599A3 Sulfone or sulfonylamine N-(heteroaralkyl)-azaheterocyclylamide compounds
BR9713921A Compound, pharmaceutical composition, process for logician capable of being modulated through factor xa inhibition
WO9825921A1 PREPARATION OF [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO[4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE